Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is ...
The 2024 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary.
To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.
In this episode, host Dr. Sally Lau moderates a discussion in Cantonese Chinese about highlights from the conference with Dr. David Lee and Dr. Molly Li.
-------- Â
25:30
Virtual Tumor Board: Stage III ALK+ NSCLC
Virtual Tumor Board: Stage III ALK+ NSCLC by IASLC
-------- Â
48:32
Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate
Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate by IASLC
-------- Â
25:28
The Benefits of Patient Advocacy Groups
In this episode of Lung Cancer Considered, host Dr. Narjust Florez engages in a discussion with patient advocate Summer Farmen. Listen to the episode to learn about Summer’s journey through diagnosis and treatment, and the importance of patient advocate groups.
• Summer Farmen
ALKtALK Program Coordinator
Board Member, ALK Positive, Inc.
-------- Â
30:07
Live from TTLC25: Targeted Therapy in SCLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on how small cell lung cancer continues to evolve with new treatment options and recent FDA approval. Listen to the episode to learn about the current standard of care and future therapies with a brief discussion about small cell transformation.
Guest: Triparna Sen, MD
Associate Professor
Director, Lung Cancer PDX Program,
Icahn School of Medicine at Mount Sinai
Guest:
Jacob Sands, MD
Assistant Professor of Medicine, Harvard Medical School
Lowe Cancer Center for Thoracic Oncology
Dana Farber Cancer Institute
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda
![Podcast Cosmosis [Formerly The UFO Rabbit Hole]](https://nz.radio.net/podcast-images/175/the-ufo-rabbit-hole-podcast.jpeg?version=aa810190eb6547a8fd808bdc7f700e9f)
New Zealand